Expand GLMD Menu
GLMD MENU

GLMD Stock Posts


Unusual Option Volume

GLMD Galmed Pharmaceuticals Ltd. -2.93+0.44 (+17.7%)

Galmed Pharmaceuticals Ltd. - trades 2,520 contracts. GLMD will report earnings on Aug 5, 2021. News: FDA Agrees with Galmed's Plan to use Aramchol Meglumine in the Randomized Double-Blind Placebo-Controlled Part of the Phase 3 ARMOR study
View Details...
GLMD stock increases 164.3% in premarket,

Premarket Gainer

GLMD Galmed Pharmaceuticals Or7.00+0.20+2.9%

Premarket:18.50+11.50 (+164.3%)

Galmed's 600 mg Aramchol Achieved a Regulatory Approvable Endpoint Showing NASH Resolution Without Worsening of Fibrosis, in NASH Patients, in the Global Phase 2b ARREST 52-Week Study

PRNewswireTue, 12-Jun 7:11 AM
Load Earlier Posts
Market Data Delayed 15 Minutes